Results 171 to 180 of about 4,583,135 (309)

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Humidtropics: Report on the Inaugural Meeting of the Independent Advisory Committee [PDF]

open access: yes, 2015
CGIAR Research Program on Integrated Systems for the Humid Tropics
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Publisher Correction: Single neuromorphic memristor closely emulates multiple synaptic mechanisms for energy efficient neural networks

open access: yesNature Communications
Christoph Weilenmann   +8 more
doaj   +1 more source

Textile Hybrid Electronics for Multifunctional Wearable Integrated Systems. [PDF]

open access: yesResearch (Wash D C)
Cai Z   +7 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Construction and applications of exosome-microneedle integrated systems. [PDF]

open access: yesInt J Pharm X
Zheng L   +6 more
europepmc   +1 more source

HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach. [PDF]

open access: yesViruses, 2022
Ward B   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy